Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 44(4); 2012 > Article
Original Article Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
Aesun Shin, MD, PhD1,2, Kyee-Zu Kim, MPH1, Kyu-Won Jung, MS2, Sohee Park, PhD2, Young-Joo Won, PhD2, Jeongseon Kim, PhD1, Dae Yong Kim, MD, PhD3, Jae Hwan Oh, MD, PhD3
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2012;44(4):219-226.
DOI: https://doi.org/10.4143/crt.2012.44.4.219
Published online: December 31, 2012

1Molecular Epidemiology Branch, National Cancer Center, Goyang, Korea.

2Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.

3Center for Colorectal Cancer, National Cancer Center, Goyang, Korea.

Corresponding author: Kyu-Won Jung, MS. Cancer Registration and Statistics Branch, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2170, Fax: 82-31-920-2179, ara@ncc.re.kr
• Received: September 28, 2012   • Accepted: November 9, 2012

Copyright © 2012 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 16,348 Views
  • 119 Download
  • 103 Crossref
  • 100 Scopus
next
Full Article

Download PDF Download PDF

  • Purpose
    This study was conducted in order to demonstrate changing trends in colorectal cancer incidence according to sex, age group, and anatomical location in the Korean population.
  • Materials and Methods
    Data from the Korea Central Cancer Registry between 1999 and 2009 were analyzed. Annual percent changes (APCs) of sex- and age-specific incidence rates for cancer of the proximal colon (International Statistical Classification of Diseases and Related Health Problems, 10th revision [ICD-10] code C18.0-18.5), distal colon (C18.6-18.7), and rectum (C19-20), and male-to-female incidence rate ratios (IRR) were calculated.
  • Results
    The age-standardized incidence rate (ASR) of colorectal cancer was 27 (per 100,000) in 1999 and increased to 50.2 in 2009 among men (APC, 6.6%). The ASR for women was 17.2 in 1999 and 26.9 in 2009 (APC, 5.1%). The rectum was the most common site of cancer among both men and women during 1999 and 2009. However, the distal colon had the highest APC (10.8% among men and 8.4% among women), followed by the proximal colon (7.9% among men and 6.6% among women), and rectum (5.2% among men and 2.4% among women). The proportion of rectal cancer decreased from 51.5% in 1999 to 47.1% in 2009 among men, and from 50.5% to 42.8% among women. An increase in the male-to-female IRR was observed for distal colon cancer and rectal cancer, whereas the IRR for proximal colon cancer was stable.
  • Conclusion
    The rapid increase in colorectal cancer incidence is mainly attributed to the increase in colon cancer, especially distal colon cancer, and may be explained by a transition of risk factors for subsites or by the effect of colorectal cancer screening.
  • Key words: Colorectal neoplasms, Incidence, Korea, Trends
Colorectal cancer is the third most common incident cancer among men and the second most common cancer among women worldwide [1]. Incidence rates vary 10-fold in both sexes worldwide, and the highest rates are estimated in more developed regions, such as North America and Western Europe, whereas the lowest rates are estimated in Africa (except Southern Africa) and South-Central Asia [1]. In Asia, colorectal cancer is the fourth most common incident cancer among men and the fifth most common cancer among women [1]. Although incidence rates are relatively low in Asian countries, those for East Asian countries are relatively high [1].
In Korea, incidence of colorectal cancer has increased. Annual percentage changes in age-standardized incidence rates were 6.2% in men and 6.8% in women between 1999 and 2009 using the world standard population as a standard population [2]. In 2009, 24,986 new colorectal cancer cases (15,068 men and 9,918 women) were diagnosed, accounting for 13.0% of all cancer occurrences [2]. Colorectal cancer is the second most common cancer after stomach cancer among men and the third most common cancer after cancers of the thyroid and breast among women [2].
There have been several reports on differences in patterns of colorectal incidence trends according to age group, sex, and anatomical location [3-5]. However, it has not been properly investigated whether colorectal cancers of a specific age group, sex, or anatomical location show more rapid increases in the Korean population. The aim of the current study was to demonstrate changing trends of colorectal cancer incidence according to age group, sex, and anatomical location.
The Korea Central Cancer Registry (KCCR), a nation-wide, hospital-based cancer registry, was initiated by the Ministry of Health and Welfare, Korea in 1980. The registry collected information on approximately 80-90% of cancer cases from more than 150 training hospitals across the country, and, in 1999, the KCCR expanded cancer registration to cover the entire Korean population under the Population-Based Regional Cancer Registry program [6]. Age (five-year intervals) and sex-specific incidence rates and the number of cases of colorectal cancer between 1999 and 2009 were obtained from the Korea National Cancer Incidence Database. Anatomical subsites were defined based on the tenth version of the International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) [7]. We defined the proximal colon as the cecum (C18.0), appendix (C18.1), ascending colon (C18.2), hepatic flexure (C18.3), transverse colon (C18.4), and splenic flexure of the colon (C18.5); the distal colon was defined as the descending colon (C18.6) and sigmoid colon (C18.7). The rectum included the rectosigmoid colon (C19) and rectum (C20). Overlapping lesions of the colon (C18.8) and colon not otherwise specified (C18.9) were not included in the subsite analysis.
Age-standardized rates (ASRs) were calculated using the middle-year population of 2,000 as the standard population. The structure of the standard population is shown in Appendix 1. Annual percent changes (APCs) for the incidence rates were calculated using a linear model, according to the following formula; (exp(b)-1)×100, where b is the slope of the regression of the natural logarithm of the ASR in a calendar year [8]. The 95% confidence intervals (CIs) were obtained with a standard error from the fit of the regression and the t-distribution function. All analyses were conducted by sex, subsite, and age group (10-year intervals). The R-2.12.2 (http://cran.r-project.org) software was used for the APC analyses. Male-to-female incidence rate ratios (IRR) were calculated using the numbers of cancer patients for each site and the sex-specific population structure for each year using Stata/SE 10.0 for Windows (Stata Corp LP, College Station, TX) [9]. Statistical significance in difference between IRRs is determined if the 95% CIs do not overlap between IRRs.
The ASRs and APCs overall and for each subsite of colorectal cancer by sex are shown in Tables 1 and 2 and Fig. 1. Among men, the ASR for colorectal cancer was 27 per 100,000 in 1999 and increased to 50.2 in 2009 (APC, 6.6%). The ASR for colorectal cancer among women was 17.2 in 1999 and 26.9 in 2009 (APC, 5.1%). The rectum was the most common cancer site among both men and women in 1999 and 2009. However, among the subsites, rectal cancer showed the lowest increase. Cancer of the distal colon showed the highest APC (10.8% among men and 8.4% among women), followed by the proximal colon (7.9% among men and 6.6% among women) and rectum (5.2% among men and 2.4% among women). As a result, the proportion of rectal cancer decreased from 51.5% in 1999 to 47.1% in 2009 among men, and from 50.5% in 1999 to 42.8% in 2009 among women, whereas the proportion of proximal and distal colon cancers increased among both men and women (Appendix 2). In all subsites, significantly higher APCs were observed among men, compared with women. As a result, the male-to-female IRRs showed a significant increase between 1999 and 2009 for overall colorectal cancer (1.20 in 1999 to 1.51 in 2009), distal colon cancer (1.32 to 1.60), and rectal cancer (1.22 to 1.67), whereas the IRR for proximal colon cancer did not show a significant change (1.09 to 1.16) (Table 3).
The ASRs and APCs for colorectal cancer subsites by age group are shown in Tables 4 and 5. For overall colorectal cancer, men who were in their 60s showed the highest increase, whereas, for women, those in their 80s showed the highest increase. Distal colon cancer consistently showed the highest APC in most age groups among both men and women, except for women in their 80s, who showed the highest APC for proximal colon cancer. Among women, for almost every subsite, the most notable increases in incidence were observed for the oldest age group. Proximal colon cancer in men also showed the highest APC in the oldest age groups, whereas APCs were significantly higher only in the 60s for distal colon cancer and 40s and 60s for rectal cancer. However, the APCs showed narrow ranges of between 10.1 and 11.7 for distal colon cancer and between 4.7 and 5.8 for rectal cancer among men over 40 years old.
The highest male-to-female IRRs for overall colorectal cancer were observed for the oldest age groups, whereas the lowest IRRs were observed for younger age groups (Table 6). However, significant increases in male-to-female IRRs were observed in their 50s and 60s between 1999 and 2009. In the subsite-specific analyses, the changes in male-to-female IRRs between 1999 and 2009 showed a statistically significantly increase for rectal cancer among men and women in their 50s, and 60s and for distal colon cancer among those in their 60s.
Incidence of colorectal cancer has increased in most countries, except for the United States and some areas of Japan [10]. The most significant increases have been observed in Eastern European countries and most Asian countries [10]. Although the Korean population has experienced a rapid increase in colorectal cancer incidence, it has not been properly investigated whether the increasing pattern differs according to age group, sex, or anatomical location. There have been suggestions that colorectal cancer incidence by subsite differs according to race, sex, age group, and time period [4,11,12]. In our study, rectal cancer accounted for the highest proportion among all subsites and ranged from 41% to 51% of all colorectal cancers. This result is consistent in part with a report from the US, which showed that the rectum (C19.9 and C20.9) was the most common subsite for male Asians and Pacific Islanders living in the US (35%), whereas the proximal colon was the most common site for Whites and Blacks among both men and women, as well as female Asians and Pacific Islanders [11,12]. However, in the current study, the APC for rectal cancer was the lowest among the subsites included, thus, it appears that the proportion of rectal cancer has decreased among both men and women in Korea. Instead, colon cancer, particularly distal colon cancer, has shown a rapid increase. We expect that the proportion of rectal cancer will continue to decrease in the future, and the proportion will eventually reach a level similar to that of Western countries.
One study suggested that incidence of colorectal cancer has increased among younger age groups in the US population, although overall incidence of colorectal cancer has declined [4]. The increases observed in the younger population were mainly attributed to rectal cancer [4]. In our study, we did not find clear evidence for a more rapid increase in overall incidence of colorectal cancer or rectal cancer in younger age groups, compared to older age groups in women. In men, however, it is worthy of mention that, unlike proximal colon cancer and distal colon cancer, where the APCs were lowest in their 30s and 40s, the APCs of rectal cancer in men in their 30s and 40s were statistically higher than those for men in their 70s and 80s.
It is notable that although the incidence was higher among men than among women, the APCs were also higher among men than among women for most subsites. As a result, the male-to-female IRR for overall colorectal cancer increased from 1.20 in 1999 to 1.51 in 2009. A high male-to-female IRR was observed for most subsites across ethnic groups in the US population [11]. Our study also showed that the lowest male-to-female IRR was observed for proximal colon cancer, indicating that the proportion of proximal colon cancer was higher among women than men. This result is consistent with results reported from the US [11], Germany [13], and Japan [14]. Traditionally, differences in the distribution of colorectal cancer subsites between men and women have been explained by the role of female hormonal factors [15,16].
Rapid increases in colorectal cancer incidence and the stabilization of colorectal cancer mortality in the Korean population could be explained by introduction of colorectal cancer screening. Colorectal cancer screening programs were introduced in 2004 as a part of the National Cancer Screening Program for Medical Aid recipients and National Health Insurance beneficiaries in the lower income bracket [17]. The fecal occult blood test (FOBT) is provided free of charge as a primary modality for men and women aged 50 years or older. FOBT-positive individuals were provided follow-up by either colonoscopy or double-contrast barium enema [17]. The participation rate was only 10.5% in 2004, however, it increased to 21.1% in 2008 [17]. According to the Korea National Cancer Screening Survey, which covers organized and opportunistic cancer screening programs, lifetime screening rates for colorectal cancer were 25.3% in 2004 and 54.2% in 2010, whereas screening rates by recommended guidelines were 19.9% in 2004 and 35.5% in 2010 [18].
In the early phase of screening, increases in incidence are due to detection of prevalent cancers. However, the introduction of colorectal cancer screening cannot completely explain the differential increase in colorectal cancer incidence by subsite. FOBT usually has a higher sensitivity for advanced neoplasia, including colorectal cancer and advanced colorectal adenomas, in the left vs. right colon [19]. This explains in part the increase in the rate of distal colon cancer, but not the low increase in rectal cancer. In addition, the National Cancer Screening Program Guidelines recommend colono-scopy or double-contrast barium enema as a follow-up modality for FOBT positive patients [17]. Sigmoidoscopy, which is used as a screening tool for an average-risk population in the US [20], is not considered as a follow-up modality in Korea. Therefore, there is little possibility that screening-detected cancers are more likely to be distal colon and rectal cancer.
A transition in risk factors may explain the differential increase in colorectal cancer according to incidence according to subsite. In a large insurance database-based study, frequent alcohol consumption and high consumption amount were more strongly associated with risk of distal colon cancer among men and risk of rectal cancer risk among women [21]. High body mass index (BMI≥25 kg/m2) was associated with increased risk for distal colon cancer among men and for proximal colon cancer among women. In addition, frequent meat intake was associated with proximal colon cancer risk among men and risk of proximal colon and rectal cancer among women [21]. Daily alcohol consumption in Korea increased from 10.6 g in 1999 to 17.3 g in 2007 among men and from 1.4 g in 1999 to 2.9 g in 2007 among women [22]. The proportion of adult men with a BMI of 25 kg/m2 and was 25.1% in 1998 and increased to 35.3% in 2008 [22]. Daily per capita meat consumption was 6.6 g in 1969 and increased to 95.1 g in 2005 [23]. In contrast, the cigarette smoking rate in the adult population decreased from 75.1% in 1992 to 43.1% in 2009 among men and from 5.1% in 1992 to 3.9% in 2009 among women [24]. Cigarette smoking has shown a stronger association with risk of rectal cancer than colon cancer [25].
In our subsite analysis, we excluded overlapping lesions of the colon (C18.8) and colon not otherwise specified (C18.9). The proportions of C18.8 did not change between 1999 and 2009 (1.0% for men and 0.8% for women), however, the proportions of C18.9 during the same period decreased from 9.8% to 5.5% among men and from 11.1% to 5.9% among women. Improved accuracy in topology classification may explain in part the increase in the incidence of distal colon cancer, however, the changes exceeded the portion that might be explained by improved accuracy in topology coding.
The rapid increase in colorectal cancer incidence in Korea between 1999 and 2009 is mainly attributed to increases in colon cancer, especially distal colon cancer. Increases in the proportion of colon cancer may be explained by a transition in risk factors for subsites and the effect of colorectal cancer screening programs. The male-to-female IRRs were higher for distal colon and rectal cancer and increased between 1999 and 2009 due to more rapid changes in male colorectal cancer incidence.
Acknowledgements
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0010276) and a research grant from the National Cancer Center of Korea (1010160).

Conflict of interest relevant to this article was not reported.

  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. 2010. cited 2012 Nov 30Lyon: International Agency for Research on Cancer; Available from: http://globocan.iarc.fr
  • 2. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44:11–24. PMID: 22500156ArticlePubMedPMCPDF
  • 3. Gupta AK, Melton LJ 3rd, Petersen GM, Timmons LJ, Vege SS, Harmsen WS, et al. Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol. 2005;3:150–158. PMID: 15704049ArticlePubMed
  • 4. Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116:4354–4359. PMID: 20734460ArticlePubMedPMC
  • 5. Meza R, Jeon J, Renehan AG, Luebeck EG. Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Res. 2010;70:5419–5429. PMID: 20530677ArticlePubMedPMC
  • 6. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 7. World Health OrganizationInternational statistical classification of diseases and related health problems. 1992-1994. 10th rev. ed. Geneva: World Health Organization.
  • 8. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. 2010. Bethesda: National Cancer Institute.
  • 9. Boyle P, Parkin DM. . In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Statistical methods for registries. Cancer registration: principles and methods. 1991. Lyon: IARC Press; p. 126–158.
  • 10. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–1694. PMID: 19505900ArticlePubMed
  • 11. Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128:1668–1675. PMID: 20503269ArticlePubMedPMC
  • 12. Wu X, Chen VW, Martin J, Roffers S, Groves FD, Correa CN, et al. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev. 2004;13:1215–1222. PMID: 15247133ArticlePubMed
  • 13. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53:57–64. PMID: 20010352ArticlePubMed
  • 14. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol. 2009;39:189–191. PMID: 19164317ArticlePubMed
  • 15. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350:991–1004. PMID: 14999111ArticlePubMed
  • 16. Yoo KY, Tajima K, Inoue M, Takezaki T, Hirose K, Hamajima N, et al. Reproductive factors related to the risk of colorectal cancer by subsite: a case-control analysis. Br J Cancer. 1999;79:1901–1906. PMID: 10206311ArticlePubMedPMC
  • 17. Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol. 2012;27:1070–1077. PMID: 22004224ArticlePubMed
  • 18. Lee EH, Lee HY, Choi KS, Jun JK, Park EC, Lee JS. Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010. Cancer Res Treat. 2011;43:141–147. PMID: 22022290ArticlePubMedPMCPDF
  • 19. Haug U, Knudsen AB, Brenner H, Kuntz KM. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn. 2011;11:605–616. PMID: 21745014ArticlePubMed
  • 20. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99–119. PMID: 20228384ArticlePubMed
  • 21. Shin A, Joo J, Bak J, Yang HR, Kim J, Park S, et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS One. 2011;6:e23196PMID: 21853085ArticlePubMedPMC
  • 22. Korea Centers for Disease Control and PreventionThe Fourth Korea National Health and Nutritional Examination Survey (KNHANES IV-2), 2008. 2009. Seoul: Korea Centers for Disease Control and Prevention.
  • 23. Kim J, Shin A, Lee JS, Youn S, Yoo KY. Dietary factors and breast cancer in Korea: an ecological study. Breast J. 2009;15:683–686. PMID: 19686228ArticlePubMed
  • 24. National Cancer Center, Ministry of Health and WelfareCancer facts and figures 2010 in the Republic of Korea. 2010. Goyang, Seoul: National Cancer Center, Ministry of Health and Welfare.
  • 25. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009;124:2406–2415. PMID: 19142968ArticlePubMed
Appendix 1

Mid-year population in 2000, Korea

Age group (yr) No. of population Weight
Total 47,534,124 1
0-4 3,262,382 0.068632
5-9 3,546,106 0.074601
10-14 3,156,497 0.066405
15-19 3,826,940 0.080509
20-24 3,923,161 0.082534
25-29 4,491,340 0.094487
30-34 4,479,771 0.094243
35-39 4,411,157 0.0928
40-44 4,067,761 0.085576
45-49 2,897,028 0.060946
50-54 2,318,703 0.04878
55-59 2,088,513 0.043937
60-64 1,796,705 0.037798
65-69 1,301,094 0.027372
70-74 883,475 0.018586
75-79 587,065 0.01235
80-84 309,500 0.006511
≥85 186,926 0.003932
Source: Korean Statistical Information Service (http://www.kosis.kr).
Appendix 2

The number of colorectal cancer cases by subsites, the Korea Central Cancer Registry, 1999 and 2009

Sites (ICD-10 code)
Year Overall
(C18.0-C20)		 Proximal colon
(C18.0-18.5)		 Distal colon
(C18.6-18.7)		 Overlapping lesion
of colon (C18.8)		 Colon, not otherwise
specified (C18.9)		 Rectum
(C19-C20)
Male 1999 5,310 932 1,069 54 521 2,734
2000 5,789 943 1,185 41 563 3,057
2001 6,525 1,144 1,394 59 599 3,329
2002 7,470 1,294 1,660 64 611 3,841
2003 8,352 1,424 1,936 73 671 4,248
2004 9,392 1,630 2,237 105 796 4,624
2005 10,606 1,810 2,670 115 790 5,221
2006 11,600 2,105 3,078 126 823 5,468
2007 12,648 2,350 3,543 119 819 5,817
2008 13,668 2,466 3,910 138 854 6,300
2009 15,068 2,808 4,185 146 829 7,100
Female 1999 4,404 850 806 35 491 2,222
2000 4,566 896 835 40 545 2,250
2001 5,143 1,101 1,017 35 493 2,497
2002 5,613 1,166 1,116 46 555 2,730
2003 6,309 1,387 1,326 62 570 2,964
2004 6,821 1,526 1,484 53 607 3,151
2005 7,609 1,727 1,731 65 690 3,396
2006 8,180 1,833 2,031 71 604 3,641
2007 8,656 2,099 2,188 74 602 3,693
2008 9,186 2,275 2,397 76 600 3,838
2009 9,918 2,402 2,600 80 591 4,245
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision.
Fig. 1
Age-standardized incidence curve for proximal colon, distal colon, and rectal cancers for male (A) and female (B) in 1999 and 2009, the Korea Central Cancer Registry.
crt-44-219-g001.jpg
Table 1
Age-standardized colorectal cancer incidence ratesa) per 100,000 and APC by subsites in male, the Korea Central Cancer Registry, 1999-2009
Sites (ICD-10 code)
Overall (C18.0-C20) Proximal colon (C18.0-C18.5) Distal colon (C18.6-C18.7) Rectum (C19-C20)
Year
 1999 27.0 4.6 5.4 13.8
 2000 28.2 4.5 5.8 14.8
 2001 30.5 5.3 6.5 15.4
 2002 33.9 5.8 7.5 17.3
 2003 36.0 6.1 8.4 18.2
 2004 38.6 6.7 9.2 18.9
 2005 41.9 7.2 10.5 20.5
 2006 44.0 8.0 11.7 20.6
 2007 45.8 8.5 12.8 21.0
 2008 47.0 8.5 13.5 21.6
 2009 50.2 9.4 13.9 23.7
APC 6.61 7.88 10.77 5.23
95% CI 6.46-6.76 7.69-8.08 10.54-11.00 5.05-5.41
p-value ＜0.001 ＜0.001 ＜0.001 ＜0.001

APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)Age adjusted to the Korean population in 2000.

Table 2
Age-standardized colorectal cancer incidence ratesa) per 100,000 and APC by subsites in female, the Korea Central Cancer Registry, 1999-2009
Sites (ICD-10 code)
Overall (C18.0-C20) Proximal colon (C18.0-C18.5) Distal colon (C18.6-C18.7) Rectum (C19-C20)
Year
 1999 17.2 3.3 3.2 8.8
 2000 17.1 3.4 3.2 8.5
 2001 18.5 4.0 3.7 9.1
 2002 19.7 4.1 4.0 9.6
 2003 21.3 4.6 4.6 10.1
 2004 22.3 4.9 5.0 10.4
 2005 23.8 5.4 5.5 10.7
 2006 24.7 5.4 6.3 11.1
 2007 25.2 6.0 6.5 10.9
 2008 25.7 6.3 6.9 10.8
 2009 26.9 6.4 7.2 11.7
APC 5.13 6.56 8.39 2.41
95% CI 4.97-5.28 5.97-7.14 7.28-9.51 1.42-3.41
p-value ＜0.001 ＜0.001 0.003 0.244

APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)Age adjusted to the Korean population in 2000.

Table 3
Male-to-female colorectal cancer IRR by subsites, the Korea Central Cancer Registry, 1999 and 2009
Year Sites (ICD-10 code)
Overall (C18.0-C20) Proximal colon (C18.0-18.5) Distal colon (C18.6-18.7) Rectum (C19-C20)
1999
 IRR 1.20 1.09 1.32 1.22
 95% CI 1.15-1.24 0.99-1.19 1.20-1.44 1.15-1.29
2009
 IRR 1.51 1.16 1.60 1.67
 95% CI 1.48-1.55 1.10-1.23 1.53-1.68 1.60-1.73

IRR, incidence rate ratios; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval.

Table 4
Incidence rates per 10,000 (1999 and 2009) and APC of colorectal cancer by subsite and age groups in male, the Korea Central Cancer Registry, 1999-2009
Sites (ICD-10 code) Age groups (yr)
30-39 40-49 50-59 60-69 70-79 ≥80
Overall (C18-C20)
 1999 6.0 20.3 59.8 125.5 206.4 232.9
 2009 10.3 33.1 114.7 257.1 377.5 389.4
 APC 5.29 6.08 6.51 6.82 6.75 5.84
 95% CI 5.03-5.55a) 5.82-6.35a) 6.29-6.73a) 6.10-7.54a) 6.56-6.94a) 5.60-6.08a)
Proximal colon (C18.0-C18.5)
 1999 1.5 4.1 10.5 21.1 32.5 30.3
 2009 2.4 5.8 18.5 45.6 82.4 77.6
 APC 5.18 4.11 6.28 9.13 10.20 10.37
 95% CI 4.63-5.73a) 3.88-4.34a) 5.92-6.64a) 8.81-9.44a) 9.89-10.51a) 9.77-10.96a)
Distal colon (C18.6-C18.7)
 1999 1.2 3.3 11.7 27.1 44.9 41.7
 2009 1.8 7.9 31.8 78.9 102.3 104.6
 APC 6.90 10.11 10.83 11.74 10.73 10.50
 95% CI 6.34-7.47a) 9.70-10.53a) 10.50-11.16a) 11.52-11.95a) 10.26-11.20a) 10.13-10.86a)
Rectum (C19-C20)
 1999 2.9 11.1 32.5 65.9 99.5 102.4
 2009 5.8 17.3 57.9 164.6 117.0 166.6
 APC 5.85 5.82 5.15 5.66 5.08 4.73
 95% CI 5.35-6.36a) 5.55-6.10a) 4.90-5.40a) 5.39-5.93a) 4.89-5.26a) 4.35-5.12a)

APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)p<0.001.

Table 5
Incidence rates per 10,000 (1999 and 2009) and annual percent change (APC) of colorectal cancer by subsite and age groups in female, the Korea Central Cancer Registry, 1999-2009
Sites (ICD-10 code) Age groups (yr)
30-39 40-49 50-59 60-69 70-79 ≥80
Overall (C18-C20)
 1999 5.7 15.7 42.0 76.5 115.7 106.7
 2009 8.1 25.0 64.2 121.1 179.6 211.3
 APC 4.26 5.10 5.34 4.46 4.84 6.73
 95% CI 3.77-4.76a) 4.87-5.33b) 5.08-5.60b) 4.03-4.90b) 4.58-5.10b) 6.52-6.95b)
Proximal colon (C18.0-C18.5)
 1999 1.0 2.4 8.3 15.5 24.6 16.2
 2009 1.3 4.3 13.7 32.3 48.1 56.9
 APC 3.41 6.26 6.40 7.62 8.29 12.66
 95% CI 2.55-4.28 5.72-6.81b) 6.14-6.66b) 7.28-7.96b) 7.84-8.73b) 12.32-13.00b)
Distal colon (C18.6-C18.7)
 1999 1.2 3.1 9.0 14.6 16.7 14.5
 2009 2.3 7.9 19.0 32.1 42.6 44.5
 APC 7.97 9.76 9.91 9.52 9.91 11.86
 95% CI 7.47-8.49b) 9.40-10.12b) 9.38-10.43b) 9.16-9.88b) 9.52-10.29b) 11.41-12.32b)
Rectum (C19-C20)
 1999 3.2 9.0 21.5 40.1 54.4 43.7
 2009 4.2 11.9 28.8 49.9 74.8 80.9
 APC 3.23 3.29 3.12 2.35 3.15 6.42
 95% CI 2.52-3.94a) 3.05-3.5b) 2.86-3.38b) 2.18-2.51b) 2.90-3.40b) 6.02-6.83b)

APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)p<0.05, b)p<0.001.

Table 6
Male-to-female colorectal cancer IRR by subsites and age groups, the Korea Central Cancer Registry, 1999 and 2009
Sites (ICD-10 code) Age groups (yr)
30-39 40-49 50-59 60-69 70-79 ≥80
Overall (C18-C20)
 1999
  IRR 1.07 1.26 1.41 1.63 1.85 2.35
  95% CI 0.89-1.28 1.12-1.43 1.29-1.54 1.51-1.76 1.68-2.03 1.96-2.81
 2009
  IRR 1.28 1.29 1.76 2.11 2.11 1.91
  95% CI 1.11-1.49 1.19-1.40 1.67-1.86 2.01-2.22 2.00-2.23 1.75-2.09
Proximal colon (C18.0-C18.5)
 1999
  IRR 1.54 1.69 1.27 1.37 1.32 1.87
  95% CI 1.04-2.32 1.27-2.27 1.04-1.55 1.15-1.62 1.07-1.62 1.22-2.86
 2009
  IRR 1.76 1.35 1.36 1.41 1.71 1.36
  95% CI 1.26-2.50 1.11-1.64 1.20-1.54 1.27-1.56 1.55-1.90 1.13-1.63
Distal colon (C18.6-C18.7)
 1999
  IRR 1.05 1.04 1.29 1.85 2.68 2.88
  95% CI 0.70-1.57 0.79-1.38 1.07-1.56 1.57-2.19 2.17-3.31 1.93-4.31
 2009
  IRR 0.82 1.01 1.68 2.46 2.40 2.35
  95% CI 0.60-1.11 0.87-1.18 1.51-1.86 2.25-2.70 2.17-2.66 1.97-2.81
Rectum (C19-C20)
 1999
  IRR 0.93 1.23 1.51 1.64 1.83 2.34
  95% CI 0.72-1.18 1.05-1.44 1.34-1.70 1.49-1.82 1.61-2.08 1.84-2.98
 2009
  IRR 1.38 1.46 2.01 2.34 2.20 2.06
  95% CI 1.13-1.68 1.31-1.64 1.86-2.18 2.17-2.52 2.04-2.38 1.80-2.35

IRR, incidence rate ratios; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • A Comparative Statistical Study of the Prevalence of Bladder and Rectal Cancer Among Patients in Najaf Province, Iraq
      Shaymaa Awad Kadhim, Hadeel Ali Hussein, Ammar Rasoul Mohammed, Haider Jaber Sagban, Emad Kareem Alsabari
      Medical Journal of Babylon.2025; 22(1): 87.     CrossRef
    • Factors influencing advanced colorectal neoplasm anatomic site distribution in China: An epidemiological study based on colorectal cancer screening data
      Kailong Zhao, Hongzhou Li, Baofeng Zhang, Wenwen Pang, Suying Yan, Xinzhu Zhao, Xinyu Liu, Wanting Wang, Qiurong Han, Yao Yao, Tianhao Chu, Zhiqiang Feng, Qinghuai Zhang, Chunze Zhang
      Cancer Medicine.2023; 12(24): 22252.     CrossRef
    • Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
      Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
      Journal of the Anus, Rectum and Colon.2022; 6(4): 231.     CrossRef
    • Trends in colorectal cancer incidence in Ho Chi Minh City, Vietnam (1996–2015): Joinpoint regression and age–period–cohort analyses
      Dung X. Pham, An H.T. Phung, Hien D. Nguyen, Tung D. Bui, Linh D. Mai, Bich N.H. Tran, Thach S. Tran, Tuan V. Nguyen, Lan T. Ho-Pham
      Cancer Epidemiology.2022; 77: 102113.     CrossRef
    • The interaction between glycemic index, glycemic load, and the genetic variant ADIPOQ T45G (rs2241766) in the risk of colorectal cancer: a case–control study in a Korean population
      Y-Thanh Lu, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      European Journal of Nutrition.2022; 61(5): 2601.     CrossRef
    • A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries
      Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
      BMC Medical Research Methodology.2022;[Epub]     CrossRef
    • A comparative analysis of factors influencing colorectal cancer’s age standardized mortality ratio among Korean women in the hot and cold spots
      ChuelWon Lee, SungMin Kim, JaeHyun Woo, Mohammad Asghari Jafarabadi
      PLOS ONE.2022; 17(9): e0273995.     CrossRef
    • Epidemiology, risk factors, and prevention of colorectal cancer
      Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
      Journal of the Korean Medical Association.2022; 65(9): 549.     CrossRef
    • Statistical methods for measuring trends in colorectal cancer incidence in registries: A systematic review
      Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients
      Kanjana Sukhokanjanachusak, Ananya Pongpaibul, Akarin Nimmannit, Charuwan Akewanlop, Krittiya Korphaisarn
      Journal of Adolescent and Young Adult Oncology.2021; 10(5): 573.     CrossRef
    • Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea
      Hayeong Khil, Sung Min Kim, SungEun Hong, Hyeon Min Gil, Eugene Cheon, Dong Hoon Lee, Young Ae Kim, NaNa Keum
      Scientific Reports.2021;[Epub]     CrossRef
    • Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients
      Hu Zhang, Jing Liu, Song-Lin Ma, Man-Lin Huang, Yan Fan, Min Song, Jing Yang, Xiao-Xia Zhang, Qi-Long Song, Jing Gong, Ping-Xiao Huang, Heng Zhang
      World Journal of Clinical Cases.2021; 9(10): 2238.     CrossRef
    • Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
      Young-Il Kim, Young Ae Kim, Hak Jin Kim, Su-Hyun Kim, Yul Hwangbo, Jae Gyu Kim, Jae J. Kim, Il Ju Choi
      The Korean Journal of Internal Medicine.2021; 36(3): 584.     CrossRef
    • Effect of antifoaming agent on benign colorectal tumors in colonoscopy: A meta-analysis
      Hu Zhang, Jing Gong, Lin-Song Ma, Ting Jiang, Heng Zhang
      World Journal of Clinical Cases.2021; 9(15): 3607.     CrossRef
    • Global colorectal cancer burden in 2020 and projections to 2040
      Yue Xi, Pengfei Xu
      Translational Oncology.2021; 14(10): 101174.     CrossRef
    • Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age
      Sun Kyung Baek, Ji Sung Lee, In Gyu Hwang, Jong Gwang Kim, Tae Won Kim, Seung Kook Sohn, Mi Yeon Kang, Sang-Cheol Lee
      The Korean Journal of Internal Medicine.2021; 36(4): 985.     CrossRef
    • Stromal Galectin-1 Promotes Colorectal Cancer Cancer-Initiating Cell Features and Disease Dissemination Through SOX9 and β-Catenin: Development of Niche-Based Biomarkers
      Kai-Yen Peng, Shih-Sheng Jiang, Yu-Wei Lee, Fang-Yu Tsai, Chia-Chi Chang, Li-Tzong Chen, B. Linju Yen
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Risk Factors for High-Risk Adenoma on the First Lifetime Colonoscopy Using Decision Tree Method: A Cross-Sectional Study in 6,047 Asymptomatic Koreans
      Kwang Hyun Chung, Min Jung Park, Eun Hyo Jin, Ji Yeon Seo, Ji Hyun Song, Sun Young Yang, Young Sun Kim, Jeong Yoon Yim, Seon Hee Lim, Joo Sung Kim, Su Jin Chung, Joo Kyung Park
      Frontiers in Medicine.2021;[Epub]     CrossRef
    • Prognostic Impact of Tumor-Associated Macrophages on Long-Term Oncologic Outcomes in Colorectal Cancer
      Hyeong Chan Shin, Incheol Seo, Hasong Jeong, Sang Jun Byun, Shin Kim, Sung Uk Bae, Sun Young Kwon, Hye Won Lee
      Life.2021; 11(11): 1240.     CrossRef
    • Postoperative Portomesenteric Venous Thrombosis After Colorectal Cancer Surgery
      Myung Jo Kim, Duck-Woo Kim, Jai Young Cho, Il Tae Son, Sung Il Kang, Heung-Kwon Oh, Sung-Bum Kang
      Journal of Gastrointestinal Surgery.2020; 24(2): 396.     CrossRef
    • Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension
      Young-Il Kim, Young Ae Kim, Jang Won Lee, Hak Jin Kim, Su-Hyun Kim, Sang Gyun Kim, Jin Il Kim, Jae J. Kim, Il Ju Choi
      Gut and Liver.2020; 14(1): 47.     CrossRef
    • Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea
      Hye Lee, Dae Hwang, Hye Han
      Oncology Letters.2020; 20(1): 655.     CrossRef
    • Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean
      Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han
      The Korean Journal of Internal Medicine.2020; 35(6): 1354.     CrossRef

    • Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers


      Soo-Jung Jung, Yu-Ri Seo, Won-Jin Park, Yu-Ran Heo, Yun-Han Lee, Shin Kim, Jae-Ho Lee
      OncoTargets and Therapy.2020; Volume 13: 12933.     CrossRef
    • Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer
      In Sub Jung, Cheol Min Shin, Sung Jae Park, Young Soo Park, Hyuk Yoon, Hyun Jin Jo, Nayoung Kim, Dong Ho Lee
      Intestinal Research.2019; 17(3): 404.     CrossRef
    • Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers
      Subbroto Kumar Saha, Yingfu Yin, Hee Sung Chae, Ssang-Goo Cho
      Cancers.2019; 11(1): 99.     CrossRef
    • Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center
      Andrea C.B. Silva, Maria Fernanda B. Vicentini, Elizabeth Z. Mendoza, Fernanda K. Fujiki, Leonardo G. da Fonseca, Maria Ignez F.M. Braghiroli, Paulo M. Hoff
      Current Problems in Cancer.2019; 43(5): 477.     CrossRef
    • Prognostic impact of telomeric repeat-containing RNA expression on long-term oncologic outcomes in colorectal cancer
      Sung Uk Bae, Won-Jin Park, Woon Kyung Jeong, Seong Kyu Baek, Hye-Won Lee, Jae-Ho Lee
      Medicine.2019; 98(14): e14932.     CrossRef
    • Novel Germline Mutations ofBRCA1andBRCA2in Korean Familial Breast Cancer Patients
      Hee Nam Kim, Min-Ho Shin, Ran Lee, Min-Ho Park, Sun-Seog Kweon
      Chonnam Medical Journal.2019; 55(2): 99.     CrossRef
    • Effects of an Internet-based informational video on preoperative anxiety in patients with colorectal cancer
      Myung Jo Kim, Heung-Kwon Oh, Keun Chul Lee, Hyun Hui Yang, Bon-Wook Koo, Jebong Lee, Min-Hyun Kim, Sung Il Kang, Duck-Woo Kim, Sung-Bum Kang
      Annals of Surgical Treatment and Research.2019; 96(6): 290.     CrossRef
    • Colorectal cancer epidemiology in Korea
      Aesun Shin, Doeun Jang, Sunho Choe, Young-Joo Won, Kyu-Won Jung, Ji Won Park, Seung-Yong Jeong
      Journal of the Korean Medical Association.2019; 62(8): 407.     CrossRef
    • Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
      NaNa Keum, Edward Giovannucci
      Nature Reviews Gastroenterology & Hepatology.2019; 16(12): 713.     CrossRef
    • Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors
      Hyejin Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Nutrients.2019; 11(11): 2612.     CrossRef
    • Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
      Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Seung-Hyun Ko, Yong Gyu Park
      Clinical and Translational Gastroenterology.2019; 10(10): e00090.     CrossRef
    • Which strategy is better for resectable synchronous liver metastasis from colorectal cancer, simultaneous surgery, or staged surgery? Multicenter retrospective analysis
      Bong-Hyeon Kye, Suk-Hwan Lee, Woon Kyung Jeong, Chang Sik Yu, In Ja Park, Hyeong Rok Kim, Jin Kim, In Kyu Lee, Ki-Jea Park, Hong-Jo Choi, Ho Young Kim, Jeong-Heum Baek, Yoon-Suk Lee
      Annals of Surgical Treatment and Research.2019; 97(4): 184.     CrossRef
    • Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial
      Cheol Min Shin, Dong Ho Lee, A Young Seo, Hyun Joo Lee, Seong Beom Kim, Woo-Chan Son, Young Kyung Kim, Sang Jun Lee, Sung-Hee Park, Nayoung Kim, Young Soo Park, Hyuk Yoon
      Clinical Nutrition.2018; 37(2): 452.     CrossRef
    • Risk and Characteristics of Postcolonoscopy Interval Colorectal Cancer after a Positive Fecal Test: A Nationwide Population-Based Study in Korea
      Chang Kyun Lee, Kui Son Choi, Chang Soo Eun, Dong-Il Park, Dong Soo Han, Minjoo Yoon, Mina Suh, Jae Kwan Jun
      Cancer Research and Treatment.2018; 50(1): 50.     CrossRef
    • Plasma phytoestrogens concentration and risk of colorectal cancer in two different Asian populations
      Kwang-Pil Ko, Yohwan Yeo, Ji-Hye Yoon, Cheong-Sik Kim, Shinkan Tokudome, Le Tran Ngoan, Chihaya Koriyama, Young-Khi Lim, Soung-Hoon Chang, Hai-Rim Shin, Daehee Kang, Sue K. Park, Chul Hwan Kang, Keun-Young Yoo
      Clinical Nutrition.2018; 37(5): 1675.     CrossRef
    • Environmental contributions to gastrointestinal and liver cancer in the Asia–Pacific region
      Kwang‐Pil Ko, Aesun Shin, Sooyoung Cho, Sue K Park, Keun‐Young Yoo
      Journal of Gastroenterology and Hepatology.2018; 33(1): 111.     CrossRef
    • Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
      Myong Cheol Lim, Young-Joo Won, Jiwon Lim, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Joo-Young Kim, Jae Hwan Oh, Robert E. Bristow, Sang-Yoon Park
      Journal of Cancer Research and Clinical Oncology.2018; 144(5): 845.     CrossRef
    • Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence
      Jihye Park, Jae Hyun Kim, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y. Jeon, Tae Il Kim, John Green
      PLOS ONE.2018; 13(3): e0193753.     CrossRef
    • Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea
      Jae Myung Cha, Mina Suh, Min Seob Kwak, Na Young Sung, Kui Son Choi, Boyoung Park, Jae Kwan Jun, Sang-Hyun Hwang, Do-Hoon Lee, Byung Chang Kim, You Kyoung Lee, Dong Soo Han
      American Journal of Gastroenterology.2018; 113(4): 611.     CrossRef
    • Long-term outcomes after stenting as a bridge to surgery in patients with obstructing left-sided colorectal cancer
      Jihye Park, Hyun Jung Lee, Soo Jung Park, Hyuk Hur, Byung Soh Min, Jae Hee Cheon, Tae Il Kim, Nam Kyu Kim, Won Ho Kim
      International Journal of Colorectal Disease.2018; 33(6): 799.     CrossRef
    • Cytoplasmic TrkA Expression as a Screen for Detecting NTRK1 Fusions in Colorectal Cancer
      Yuri Choi, Yeo-Jin Won, Sojeong Lee, Ahrong Kim, Younggeum Kim, Won-Young Park, Hong-Jae Jo, Geun Am Song, Chae Hwa Kwon, Do Youn Park
      Translational Oncology.2018; 11(3): 764.     CrossRef
    • Updates on Cancer Epidemiology in Korea, 2018
      Sun-Seog Kweon
      Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
    • Korean physicians’ policies for postoperative surveillance of colorectal cancer
      Sun Kyung Baek, Sang-Cheol Lee, Jong Gwang Kim, Jun Won Um, Suk-Hwan Lee, Byung Ik Jang, Jae Jun Park, Tae Won Kim
      The Korean Journal of Internal Medicine.2018; 33(4): 783.     CrossRef
    • Intestinal microbiota, chronic inflammation, and colorectal cancer
      Chan Hyuk Park, Chang Soo Eun, Dong Soo Han
      Intestinal Research.2018; 16(3): 338.     CrossRef
    • Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer
      Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han, Cheol Min Shin, Nayoung Kim
      European Journal of Epidemiology.2018; 33(11): 1077.     CrossRef
    • Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data
      Hyuk Hur, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
      Annals of Coloproctology.2018; 34(4): 212.     CrossRef
    • Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer
      Sung Uk Bae, Kyoung Sook Won, Bong-Il Song, Woon Kyung Jeong, Seong Kyu Baek, Hae Won Kim
      Cancer Imaging.2018;[Epub]     CrossRef
    • Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea
      Dong Woo Shin, Yoon Jin Choi, Hyun Soo Kim, Kyung-Do Han, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
      Diseases of the Colon & Rectum.2018; 61(11): 1250.     CrossRef
    • Prognostic impact of programmed cell death ligand 1 expression on long‑term oncologic outcomes in colorectal cancer
      Sung Bae, Woon Jeong, Seong Baek, Nam Kim, Ilseon Hwang
      Oncology Letters.2018;[Epub]     CrossRef
    • Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia
      Seohui Lee, Byeong Gwan Kim, Ji Won Kim, Kook Lae Lee, Dae Lim Koo, Hyunwoo Nam, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh
      Gastrointestinal Endoscopy.2017; 85(3): 568.     CrossRef
    • Association between dietary fat intake and colorectal adenoma in korean adults
      Jeehyun Kim, Seung-Won Oh, Young-Sun Kim, Hyuktae Kwon, Hee-Kyung Joh, Ji-Eun Lee, Danbee Park, Jae-Hong Park, Ah-Ryoung Ko, Ye-Ji Kim
      Medicine.2017; 96(1): e5759.     CrossRef
    • Dietary Flavonoids, CYP1A1 Genetic Variants, and the Risk of Colorectal Cancer in a Korean population
      Young Ae Cho, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Scientific Reports.2017;[Epub]     CrossRef
    • The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia
      Mahshid Ghoncheh, Maryam Mohammadian, Abdollah Mohammadian-Hafshejani, Hamid Salehiniya
      Annals of Global Health.2017; 82(5): 726.     CrossRef
    • The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
      Daeyoun David Won, Jae Im Lee, In Kyu Lee, Seong-Taek Oh, Eun Sun Jung, Sung Hak Lee
      BMC Cancer.2017;[Epub]     CrossRef
    • A Case of Metastatic Rectal Carcinoma to the Frontal Sinus
      Seok Kim, Tae Young Jung, Bo Young Kim, Tae Jung Park
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2017; 60(6): 314.     CrossRef
    • Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells
      Dong Hwan Kim, Min Jeong Kim, Bokyung Sung, Hongsuk Suh, Jee H. Jung, Hae Young Chung, Nam Deuk Kim
      Oncology Reports.2017; 37(1): 281.     CrossRef
    • Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service–National Sample Cohort
      Cheol Min Shin, Kyungdo Han, Dong Ho Lee, Yoon Jin Choi, Nayoung Kim, Young Soo Park, Hyuk Yoon
      Diseases of the Colon & Rectum.2017; 60(11): 1192.     CrossRef
    • Two case reports
      Chang hoon Ahn, Soon Chul Kim
      Medicine.2017; 96(46): e8074.     CrossRef
    • Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer
      Dalyong Kim, Sun Young Kim, Ji Sung Lee, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jihun Kim, Se Jin Jang, Young-Kwang Yoon, Tae Won Kim
      BMC Gastroenterology.2017;[Epub]     CrossRef
    • The Effects of Physical Activity and Body Fat Mass on Colorectal Polyp Recurrence in Patients with Previous Colorectal Cancer
      Jihye Park, Jae Hyun Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y. Jeon, Tae Il Kim
      Cancer Prevention Research.2017; 10(8): 478.     CrossRef
    • Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
      Hyun Joo Jang, Eun Mi Hong, Juah Jang, Jung Eun Choi, Se Woo Park, Hyun Woo Byun, Dong Hee Koh, Min Ho Choi, Sea Hyub Kae, Jin Lee
      Gastroenterology Research and Practice.2016; 2016: 1.     CrossRef
    • Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
      Sung Keun Jung, Chul-Ho Jeong
      Journal of Cancer Prevention.2016; 21(1): 26.     CrossRef
    • Colorectal cancer screening of the general population in East Asia
      Yasushi Sano, Jeong‐Sik Byeon, Xiao‐Bo Li, Martin C.S. Wong, Han‐Mo Chiu, Rungsun Rerknimitr, Takahiro Utsumi, Santa Hattori, Wataru Sano, Mineo Iwatate, Philip Chiu, Joseph Sung
      Digestive Endoscopy.2016; 28(3): 243.     CrossRef
    • Cancer Mortality Projections in Korea up to 2032
      Mia Son, Jae-Won Yun
      Journal of Korean Medical Science.2016; 31(6): 892.     CrossRef
    • Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway
      Jeong Mo Bae, Jung Ho Kim, Gyeong Hoon Kang
      Archives of Pathology & Laboratory Medicine.2016; 140(5): 406.     CrossRef
    • Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
      Eunyoung Lee, Sung-Bum Kang, Sang Il Choi, Eun Ju Chun, Min Jeong Kim, Duck-Woo Kim, Heung-Kwon Oh, Myong Hoon Ihn, Jin Won Kim, Soo-Mee Bang, Jeong-Ok Lee, Yu Jung Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee
      Cancer Research and Treatment.2016; 48(3): 978.     CrossRef
    • Dietary Inflammatory Index and Risk of Colorectal Cancer: A Case-Control Study in Korea
      Young Cho, Jeonghee Lee, Jae Oh, Aesun Shin, Jeongseon Kim
      Nutrients.2016; 8(8): 469.     CrossRef
    • Colorectal cancer incidence in 5 Asian countries by subsite: An analysis of Cancer Incidence in Five Continents (1998–2007)
      Hye-Min Park, Hyeongtaek Woo, Sun Jae Jung, Kyu-Won Jung, Hai-Rim Shin, Aesun Shin
      Cancer Epidemiology.2016; 45: 65.     CrossRef
    • Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses
      Hyun-Jeong Shim, Ran Lee, Min-Ho Shin, Hee-Nam Kim, Sun-Seog Kweon
      Cancer Epidemiology.2016; 45: 108.     CrossRef
    • Prevalence of colorectal neoplasms in young, average risk individuals: A turning tide between East and West
      Ari Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Alfred I Neugut, Nadir Arber, Erwin Santo
      World Journal of Gastroenterology.2016; 22(32): 7365.     CrossRef
    • Young‐onset colorectal cancer in the Asia–Pacific region
      Moe Kyaw, Joseph JY Sung
      Medical Journal of Australia.2016; 205(10): 450.     CrossRef
    • Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer
      Chan Kwon Jung, Seung-Hyun Jung, Seon-Hee Yim, Ji-Han Jung, Hyun Joo Choi, Won-Kyung Kang, Sung-Won Park, Seong-Taek Oh, Jun-Gi Kim, Sug Hyung Lee, Yeun-Jun Chung
      Oncotarget.2016; 7(22): 32902.     CrossRef
    • NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer
      Do Youn Park, Chan Choi, Eunji Shin, Jae Hyuk Lee, Chae Hwa Kwon, Hong-Jae Jo, Hyeong-Rok Kim, Hyun Sung Kim, Nahmgun Oh, Ji Shin Lee, Ok Ku Park, Eok Park, Jonghoon Park, Jong-Yeon Shin, Jong-Il Kim, Jeong-Sun Seo, Hee Dong Park, Joonghoon Park
      Oncotarget.2016; 7(7): 8399.     CrossRef
    • The Role of Fibrinogen as a Predictor in Preoperative Chemoradiation for Rectal Cancer
      Jong Hoon Lee, Jong Hee Hyun, Dae Yong Kim, Byong Chul Yoo, Ji Won Park, Sun Young Kim, Hee Jin Chang, Byung Chang Kim, Tae Hyun Kim, Jae Hwan Oh, Dae Kyung Sohn
      Annals of Surgical Oncology.2015; 22(1): 209.     CrossRef
    • The colorectal cancer mortality‐to‐incidence ratio as an indicator of global cancer screening and care
      Vasu Sunkara, James R. Hébert
      Cancer.2015; 121(10): 1563.     CrossRef
    • Randomized Controlled Trial of Sodium Phosphate Tablets versus 2 L Polyethylene Glycol Solution for Bowel Cleansing prior to Colonoscopy
      Yun Ho Lee, Seong Yeon Jeong, You Sun Kim, Hye Jin Jung, Min Jung Kwon, Cheol Hun Kwak, Song I Bae, Jeong Seop Moon, Ji Won Kim, Su Hwan Kim, Kook Lae Lee
      The Korean Journal of Gastroenterology.2015; 65(1): 27.     CrossRef
    • Difference in Time to Locoregional Recurrence Between Patients With Right-Sided and Left-Sided Colon Cancers
      Jung Hun Park, Min Jung Kim, Sung Chan Park, Min Ju Kim, Chang Won Hong, Dae Kyung Sohn, Kyung Su Han, Jae Hwan Oh
      Diseases of the Colon & Rectum.2015; 58(9): 831.     CrossRef
    • Cost comparison between endoscopic submucosal dissection and transanal endoscopic microsurgery for the treatment of rectal tumors
      Myung Jin Nam, Dae Kyung Sohn, Chang Won Hong, Kyung Su Han, Byung Chang Kim, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh
      Annals of Surgical Treatment and Research.2015; 89(4): 202.     CrossRef
    • Influence of old age on the postoperative outcomes of obstructive colorectal cancer surgery after the insertion of a stent
      Chan Hee Park, Seong Kyu Baek, Ok Suk Bae, Woon Kyung Jeong
      Annals of Surgical Treatment and Research.2015; 89(4): 183.     CrossRef
    • Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
      Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
      Journal of agricultural medicine and community health.2015; 40(3): 115.     CrossRef
    • Trends in major cancer mortality in Korea, 1983–2012, with a joinpoint analysis
      Daroh Lim, Mina Ha, Inmyung Song
      Cancer Epidemiology.2015; 39(6): 939.     CrossRef
    • Changing trends in colorectal cancer in the Republic of Korea: contrast with Japan
      Minjoo Yoon, Nicholas Kim, Byungho Nam, Jungnam Joo, Moran Ki
      Epidemiology and Health.2015; 37: e2015038.     CrossRef
    • Temporal Epidemiological Assessment of Colorectal Cancer Incidence and Mortality in East Kazakhstan, 2004-2013
      Kuantkan Zhabagin, Nurbek Igissinov, Zukhra Manambayeva, Tasbolat Adylkhanov, Marat Sandybayev, Murat Nurgazin, Adilzhan Massadykov, Sayat Tanatarov, Daniyar Aldyngurov, Nailya Urazalina, Aizhan Abiltayeva, Ainoor Baissalbayeva, Almagul Zhabagina, Dinara
      Asian Pacific Journal of Cancer Prevention.2015; 16(15): 6413.     CrossRef
    • Isoflavone and Soyfood Intake and Colorectal Cancer Risk: A Case-Control Study in Korea
      Aesun Shin, Jeonghee Lee, Jeeyoo Lee, Moon Sung Park, Ji Won Park, Sung Chan Park, Jae Hwan Oh, Jeongseon Kim, Ajay Goel
      PLOS ONE.2015; 10(11): e0143228.     CrossRef
    • Gender-specific Colorectal Cancer: Epidemiologic Difference and Role of Estrogen
      Hee Man Kim, Hyun-Soo Kim
      The Korean Journal of Gastroenterology.2014; 63(4): 201.     CrossRef
    • A Survey of Colonoscopic Surveillance After Polypectomy
      Dae Kyung Sohn
      Annals of Coloproctology.2014; 30(2): 88.     CrossRef
    • Colonoscopy Quality is the Answer for the Emerging Issue of Interval Cancer
      Jae Myung Cha
      Intestinal Research.2014; 12(2): 110.     CrossRef
    • Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database
      H.‐Y. Yhim, M.‐J. Jang, S.‐M. Bang, K.H. Kim, Y.‐K. Kim, S.‐H. Nam, S.H. Bae, S.‐H. Kim, Y.‐C. Mun, I. Kim, C.W. Jung, D. Oh
      Journal of Thrombosis and Haemostasis.2014; 12(7): 1035.     CrossRef
    • Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients
      Su Young Lee, Byung Chang Kim, Kyung Su Han, Chang Won Hong, Dae Kyung Sohn, Sung Chan Park, Sun Young Kim, Ji‐Yeon Baek, Hee Jin Chang, Dae Yong Kim, Jae Hwan Oh
      Journal of Digestive Diseases.2014; 15(7): 367.     CrossRef
    • Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: The Korean Cancer Prevention Study-II
      Hyun-Young Shin, Keum Ji Jung, John A. Linton, Sun Ha Jee
      Metabolism.2014; 63(10): 1250.     CrossRef
    • Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy
      Hui Zhu, Xuejing Yang, Jiali Li, Yanjie Ren, Tianyu Zhang, Chunze Zhang, Jintai Zhang, Jing Li, Yan Pang
      BioMed Research International.2014; 2014: 1.     CrossRef
    • Tumor SUVmax Normalized to Liver Uptake on 18F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
      Jihyun Park, Kyoung Jin Chang, Young Seok Seo, Byung Hyun Byun, Joon Ho Choi, Hansol Moon, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Sang Moo Lim
      Nuclear Medicine and Molecular Imaging.2014; 48(4): 295.     CrossRef
    • Risk Prediction Model for Colorectal Cancer: National Health Insurance Corporation Study, Korea
      Aesun Shin, Jungnam Joo, Hye-Ryung Yang, Jeongin Bak, Yunjin Park, Jeongseon Kim, Jae Hwan Oh, Byung-Ho Nam, Zhengdong Zhang
      PLoS ONE.2014; 9(2): e88079.     CrossRef
    • Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells
      YUJIN LEE, BOKYUNG SUNG, YONG JUNG KANG, DONG HWAN KIM, JUNG-YOON JANG, SEONG YEON HWANG, MINJUNG KIM, HYUN SOOK LIM, JEONG-HYUN YOON, HAE YOUNG CHUNG, NAM DEUK KIM
      International Journal of Oncology.2014; 44(5): 1599.     CrossRef
    • Overview of Cancer Registration Research in the Asian Pacific from 2008-2013
      Malcolm A. Moore
      Asian Pacific Journal of Cancer Prevention.2013; 14(8): 4461.     CrossRef
    • Clinical Practice of Surveillance Colonoscopy according to the Classification of Colorectal Intraepithelial Neoplasia in Korea: High-grade Dysplasia/CarcinomaIn SituVersus Intramucosal Carcinoma
      Sung Pil Hong, Tae Il Kim, Hyun Gun Kim, Hyun-Soo Kim, Seong-Eun Kim, Kyu Chan Huh, Jeong Eun Shin, Jae Myung Cha, Suck-Ho Lee
      Intestinal Research.2013; 11(4): 276.     CrossRef
    • Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010
      Myong Cheol Lim, Eun-Kyeong Moon, Aesun Shin, Kyu-Won Jung, Young-Joo Won, Sang Soo Seo, Sokbom Kang, Jae-Weon Kim, Joo-Young Kim, Sang-Yoon Park
      Journal of Gynecologic Oncology.2013; 24(4): 298.     CrossRef
    • Short-term and long-term outcome after laparoscopic elective radical rectal cancer resection in octogenarians: is it really a safe procedure?
      Jiae Park, Seok In Seo, Duk-Won Hwang, Ho Suk Lee
      Korean Journal of Clinical Oncology.2013; 9(2): 148.     CrossRef
    • Treatment Strategy for Elderly Patients with Metastatic Colorectal Cancer: A Review of the Systemic Chemotherapy Options
      Yong Sang Hong, Jee Hyun Kim, Tae Won Kim
      Current Colorectal Cancer Reports.2013; 9(3): 213.     CrossRef
    • Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry
      Hyoung-Chul Park, Aesun Shin, Byung-Woo Kim, Kyu-Won Jung, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
      Annals of Coloproctology.2013; 29(4): 144.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
      Cancer Res Treat. 2012;44(4):219-226.   Published online December 31, 2012
      DOI: https://doi.org/10.4143/crt.2012.44.4.219
      Close
    • XML DownloadXML Download
    • 0
    Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
    Image
    Fig. 1 Age-standardized incidence curve for proximal colon, distal colon, and rectal cancers for male (A) and female (B) in 1999 and 2009, the Korea Central Cancer Registry.

    Fig. 1

    Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
    Sites (ICD-10 code)
    Overall (C18.0-C20) Proximal colon (C18.0-C18.5) Distal colon (C18.6-C18.7) Rectum (C19-C20)
    Year
     1999 27.0 4.6 5.4 13.8
     2000 28.2 4.5 5.8 14.8
     2001 30.5 5.3 6.5 15.4
     2002 33.9 5.8 7.5 17.3
     2003 36.0 6.1 8.4 18.2
     2004 38.6 6.7 9.2 18.9
     2005 41.9 7.2 10.5 20.5
     2006 44.0 8.0 11.7 20.6
     2007 45.8 8.5 12.8 21.0
     2008 47.0 8.5 13.5 21.6
     2009 50.2 9.4 13.9 23.7
    APC 6.61 7.88 10.77 5.23
    95% CI 6.46-6.76 7.69-8.08 10.54-11.00 5.05-5.41
    p-value ＜0.001 ＜0.001 ＜0.001 ＜0.001
    Sites (ICD-10 code)
    Overall (C18.0-C20) Proximal colon (C18.0-C18.5) Distal colon (C18.6-C18.7) Rectum (C19-C20)
    Year
     1999 17.2 3.3 3.2 8.8
     2000 17.1 3.4 3.2 8.5
     2001 18.5 4.0 3.7 9.1
     2002 19.7 4.1 4.0 9.6
     2003 21.3 4.6 4.6 10.1
     2004 22.3 4.9 5.0 10.4
     2005 23.8 5.4 5.5 10.7
     2006 24.7 5.4 6.3 11.1
     2007 25.2 6.0 6.5 10.9
     2008 25.7 6.3 6.9 10.8
     2009 26.9 6.4 7.2 11.7
    APC 5.13 6.56 8.39 2.41
    95% CI 4.97-5.28 5.97-7.14 7.28-9.51 1.42-3.41
    p-value ＜0.001 ＜0.001 0.003 0.244
    Year Sites (ICD-10 code)
    Overall (C18.0-C20) Proximal colon (C18.0-18.5) Distal colon (C18.6-18.7) Rectum (C19-C20)
    1999
     IRR 1.20 1.09 1.32 1.22
     95% CI 1.15-1.24 0.99-1.19 1.20-1.44 1.15-1.29
    2009
     IRR 1.51 1.16 1.60 1.67
     95% CI 1.48-1.55 1.10-1.23 1.53-1.68 1.60-1.73
    Sites (ICD-10 code) Age groups (yr)
    30-39 40-49 50-59 60-69 70-79 ≥80
    Overall (C18-C20)
     1999 6.0 20.3 59.8 125.5 206.4 232.9
     2009 10.3 33.1 114.7 257.1 377.5 389.4
     APC 5.29 6.08 6.51 6.82 6.75 5.84
     95% CI 5.03-5.55a) 5.82-6.35a) 6.29-6.73a) 6.10-7.54a) 6.56-6.94a) 5.60-6.08a)
    Proximal colon (C18.0-C18.5)
     1999 1.5 4.1 10.5 21.1 32.5 30.3
     2009 2.4 5.8 18.5 45.6 82.4 77.6
     APC 5.18 4.11 6.28 9.13 10.20 10.37
     95% CI 4.63-5.73a) 3.88-4.34a) 5.92-6.64a) 8.81-9.44a) 9.89-10.51a) 9.77-10.96a)
    Distal colon (C18.6-C18.7)
     1999 1.2 3.3 11.7 27.1 44.9 41.7
     2009 1.8 7.9 31.8 78.9 102.3 104.6
     APC 6.90 10.11 10.83 11.74 10.73 10.50
     95% CI 6.34-7.47a) 9.70-10.53a) 10.50-11.16a) 11.52-11.95a) 10.26-11.20a) 10.13-10.86a)
    Rectum (C19-C20)
     1999 2.9 11.1 32.5 65.9 99.5 102.4
     2009 5.8 17.3 57.9 164.6 117.0 166.6
     APC 5.85 5.82 5.15 5.66 5.08 4.73
     95% CI 5.35-6.36a) 5.55-6.10a) 4.90-5.40a) 5.39-5.93a) 4.89-5.26a) 4.35-5.12a)
    Sites (ICD-10 code) Age groups (yr)
    30-39 40-49 50-59 60-69 70-79 ≥80
    Overall (C18-C20)
     1999 5.7 15.7 42.0 76.5 115.7 106.7
     2009 8.1 25.0 64.2 121.1 179.6 211.3
     APC 4.26 5.10 5.34 4.46 4.84 6.73
     95% CI 3.77-4.76a) 4.87-5.33b) 5.08-5.60b) 4.03-4.90b) 4.58-5.10b) 6.52-6.95b)
    Proximal colon (C18.0-C18.5)
     1999 1.0 2.4 8.3 15.5 24.6 16.2
     2009 1.3 4.3 13.7 32.3 48.1 56.9
     APC 3.41 6.26 6.40 7.62 8.29 12.66
     95% CI 2.55-4.28 5.72-6.81b) 6.14-6.66b) 7.28-7.96b) 7.84-8.73b) 12.32-13.00b)
    Distal colon (C18.6-C18.7)
     1999 1.2 3.1 9.0 14.6 16.7 14.5
     2009 2.3 7.9 19.0 32.1 42.6 44.5
     APC 7.97 9.76 9.91 9.52 9.91 11.86
     95% CI 7.47-8.49b) 9.40-10.12b) 9.38-10.43b) 9.16-9.88b) 9.52-10.29b) 11.41-12.32b)
    Rectum (C19-C20)
     1999 3.2 9.0 21.5 40.1 54.4 43.7
     2009 4.2 11.9 28.8 49.9 74.8 80.9
     APC 3.23 3.29 3.12 2.35 3.15 6.42
     95% CI 2.52-3.94a) 3.05-3.5b) 2.86-3.38b) 2.18-2.51b) 2.90-3.40b) 6.02-6.83b)
    Sites (ICD-10 code) Age groups (yr)
    30-39 40-49 50-59 60-69 70-79 ≥80
    Overall (C18-C20)
     1999
      IRR 1.07 1.26 1.41 1.63 1.85 2.35
      95% CI 0.89-1.28 1.12-1.43 1.29-1.54 1.51-1.76 1.68-2.03 1.96-2.81
     2009
      IRR 1.28 1.29 1.76 2.11 2.11 1.91
      95% CI 1.11-1.49 1.19-1.40 1.67-1.86 2.01-2.22 2.00-2.23 1.75-2.09
    Proximal colon (C18.0-C18.5)
     1999
      IRR 1.54 1.69 1.27 1.37 1.32 1.87
      95% CI 1.04-2.32 1.27-2.27 1.04-1.55 1.15-1.62 1.07-1.62 1.22-2.86
     2009
      IRR 1.76 1.35 1.36 1.41 1.71 1.36
      95% CI 1.26-2.50 1.11-1.64 1.20-1.54 1.27-1.56 1.55-1.90 1.13-1.63
    Distal colon (C18.6-C18.7)
     1999
      IRR 1.05 1.04 1.29 1.85 2.68 2.88
      95% CI 0.70-1.57 0.79-1.38 1.07-1.56 1.57-2.19 2.17-3.31 1.93-4.31
     2009
      IRR 0.82 1.01 1.68 2.46 2.40 2.35
      95% CI 0.60-1.11 0.87-1.18 1.51-1.86 2.25-2.70 2.17-2.66 1.97-2.81
    Rectum (C19-C20)
     1999
      IRR 0.93 1.23 1.51 1.64 1.83 2.34
      95% CI 0.72-1.18 1.05-1.44 1.34-1.70 1.49-1.82 1.61-2.08 1.84-2.98
     2009
      IRR 1.38 1.46 2.01 2.34 2.20 2.06
      95% CI 1.13-1.68 1.31-1.64 1.86-2.18 2.17-2.52 2.04-2.38 1.80-2.35
    Table 1 Age-standardized colorectal cancer incidence ratesa) per 100,000 and APC by subsites in male, the Korea Central Cancer Registry, 1999-2009

    APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)Age adjusted to the Korean population in 2000.

    Table 2 Age-standardized colorectal cancer incidence ratesa) per 100,000 and APC by subsites in female, the Korea Central Cancer Registry, 1999-2009

    APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)Age adjusted to the Korean population in 2000.

    Table 3 Male-to-female colorectal cancer IRR by subsites, the Korea Central Cancer Registry, 1999 and 2009

    IRR, incidence rate ratios; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval.

    Table 4 Incidence rates per 10,000 (1999 and 2009) and APC of colorectal cancer by subsite and age groups in male, the Korea Central Cancer Registry, 1999-2009

    APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)p<0.001.

    Table 5 Incidence rates per 10,000 (1999 and 2009) and annual percent change (APC) of colorectal cancer by subsite and age groups in female, the Korea Central Cancer Registry, 1999-2009

    APC, annual percent change; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval. a)p<0.05, b)p<0.001.

    Table 6 Male-to-female colorectal cancer IRR by subsites and age groups, the Korea Central Cancer Registry, 1999 and 2009

    IRR, incidence rate ratios; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th revision; CI, confidence interval.

    Table 1

    Table 2

    Table 3

    Table 4

    Table 5

    Table 6

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP